Andersson K E, Bertler A, Redfors A
Eur J Clin Pharmacol. 1975 Aug 14;8(6):421-5. doi: 10.1007/BF00562316.
The plasma concentration of proscillaridin was measured by a modified 86Rb method during treatment with multiple doses of a commercial preparation of proscillaridin. Despite high doses, very low plasma levels were found, and there were only minute amounts of glycoside activity in urine and faeces. Administration of an enteric-coated proscillaridin preparation gave higher plasma levels, which raises the possibility of inactivation of the glycoside by acid gastric juice. The results suggest that proscillaridin has low biological availability when given orally, and that it is extensively metabolised in the body.
在用多次剂量的海葱苷商业制剂治疗期间,通过改良的⁸⁶Rb方法测量了海葱苷的血浆浓度。尽管剂量很高,但发现血浆水平非常低,并且尿液和粪便中只有微量的糖苷活性。给予肠溶包衣的海葱苷制剂可使血浆水平升高,这增加了糖苷被胃酸灭活的可能性。结果表明,海葱苷口服时生物利用度较低,且在体内被广泛代谢。